vimarsana.com

Latest Breaking News On - Anticancer - Page 3 : vimarsana.com

Fasting as an Effective Anti-Cancer Strategy: Inspiring Success Stories

Fasting has gained much popularity in recent years. In addition to its weight loss benefits, research has found .

Japan
Taiwan
China
Brussels
Bruxelles-capitale
Belgium
United-states
Chinese
Japanese
American
Yoshinori-ohsumi
Shukan-josei

Study: Eating BROCCOLI can protect against LIVER CANCER and fatty liver

Consuming broccoli can protect against liver cancer and stop the development of fatty liver in its tracks, according to a paper published in Oncology Research Featuring Preclinical and Clinical [.]

United-states
American
Americans
David-wilkinson
Elizabeth-jeffery
Health-tips
Oncology-research-featuring-preclinical
Central-south-university
University-of-illinois
Natural-news
Clinical-cancer
Food-be-medicine-against

Study: Supplementing with vitamin D helps prevent cancer, especially if it's taken more frequently

Many people are already aware of the bone-protective effects of vitamin D, but did you also know that the "sunlight nutrient" protects against cancer? Researchers from the German Cancer [.]

Germany
German
German-cancer-research-center
Natural-news
Vitamind-infographic
Ben-sch
Alternative-medicine
Cancer
Health
Medicine
Nutrition

"Anticancer activity of Indonesian Melia azedarach L.: Phyto-chemistry," by Ari Satia Nugraha, Lilla Nur Firli et al.

This study describes the isolation of bioactive compounds and their in vitro anticancer activities from Melia azedarach L leaves from Karanglor, Karangan, Karanganom Klaten, Central Java-Indonesia. Isolated and characterised were the phenolics, kaempferol 7-O-rutinoside 1 and 4-methoxyresorcinol 3, The anticancer activity of the crude methanol extract of M. azedarach against a number cell lines (LNCaP, MDA-MB-231, and MCF-7) was found to be moderate; kaempferol derivatives were notable for their antiproliferative activities. Computational analysis, including molecular docking simulations and molecular dynamic studies, were used to investigate the feasibility of radiolabelled versions of 1 and 3 as theranostic agents targeting tyrosine kinase-type cell surface receptor HER2 in cancer - the iodinated derivatives 2 and 4, respectively, were used in this investigation as surrogates. The corresponding radioiodinated 2 and 4 were found to have high binding affinities of 10.1 and 5.7 kcal/mol

Indonesia
Karangan
Jawa-timur
Central-java
Jawa-tengah
Karanglor
Karanganom-klaten
Anticancer
Kaempferol
Elia-azedarach-l
Hytochemistry

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.